GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spermosens AB (XSAT:SPERM) » Definitions » Piotroski F-Score

Spermosens AB (XSAT:SPERM) Piotroski F-Score : 4 (As of Apr. 01, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Spermosens AB Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Spermosens AB has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Spermosens AB's Piotroski F-Score or its related term are showing as below:

XSAT:SPERM' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 4
Current: 4

During the past 6 years, the highest Piotroski F-Score of Spermosens AB was 4. The lowest was 2. And the median was 3.


Spermosens AB Piotroski F-Score Historical Data

The historical data trend for Spermosens AB's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spermosens AB Piotroski F-Score Chart

Spermosens AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial N/A N/A 2.00 3.00 4.00

Spermosens AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.00 2.00 2.00 4.00

Competitive Comparison of Spermosens AB's Piotroski F-Score

For the Diagnostics & Research subindustry, Spermosens AB's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spermosens AB's Piotroski F-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spermosens AB's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Spermosens AB's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was -3.216 + -2.367 + -2.162 + -2.459 = kr-10.20 Mil.
Cash Flow from Operations was -1.3 + -5.648 + -1.78 + -1.262 = kr-9.99 Mil.
Revenue was 0 + 0 + 0 + 0 = kr0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = kr0.00 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(26.105 + 23.82 + 27.302 + 24.995 + 31.044) / 5 = kr26.6532 Mil.
Total Assets at the begining of this year (Dec23) was kr26.11 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Total Current Assets was kr6.25 Mil.
Total Current Liabilities was kr3.70 Mil.
Net Income was -3.275 + -3.429 + -3.505 + -1.993 = kr-12.20 Mil.

Revenue was 0 + 0 + 0 + 0 = kr0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = kr0.00 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(9.664 + 48.478 + 45.421 + 50.959 + 26.105) / 5 = kr36.1254 Mil.
Total Assets at the begining of last year (Dec22) was kr9.66 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.23 Mil.
Total Current Assets was kr5.72 Mil.
Total Current Liabilities was kr13.18 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Spermosens AB's current Net Income (TTM) was -10.20. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Spermosens AB's current Cash Flow from Operations (TTM) was -9.99. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=-10.204/26.105
=-0.39088297

ROA (Last Year)=Net Income/Total Assets (Dec22)
=-12.202/9.664
=-1.26262417

Spermosens AB's return on assets of this year was -0.39088297. Spermosens AB's return on assets of last year was -1.26262417. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Spermosens AB's current Net Income (TTM) was -10.20. Spermosens AB's current Cash Flow from Operations (TTM) was -9.99. ==> -9.99 > -10.20 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=0/26.6532
=0

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=0.23/36.1254
=0.00636671

Spermosens AB's gearing of this year was 0. Spermosens AB's gearing of last year was 0.00636671. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=6.247/3.699
=1.68883482

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=5.715/13.183
=0.43351286

Spermosens AB's current ratio of this year was 1.68883482. Spermosens AB's current ratio of last year was 0.43351286. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Spermosens AB's number of shares in issue this year was 1350.51. Spermosens AB's number of shares in issue last year was 41.194. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0/0
=

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0/0
=

Spermosens AB's gross margin of this year was . Spermosens AB's gross margin of last year was . ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=0/26.105
=0

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=0/9.664
=0

Spermosens AB's asset turnover of this year was 0. Spermosens AB's asset turnover of last year was 0. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+1+0+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Spermosens AB has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Spermosens AB  (XSAT:SPERM) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Spermosens AB Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Spermosens AB's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Spermosens AB Business Description

Traded in Other Exchanges
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment. It is a developer of medical device products for male infertility, individualizing In Vitro Fertilization (IVF) diagnostics and treatment creating a new standard for faster and safer IVF treatments.

Spermosens AB Headlines

No Headlines